Physician profile
Robert K Tatum
NPI 1699798884
$1,728.80
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $233 · 2021: $542 · 2022: $500 · 2023: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $720.69 | 2019-2023 | Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $138.44 | 2019-2022 | |
| Exeltis, USA INC. | $107.28 | 2021-2022 | |
| Avion Pharmaceuticals | $101.46 | 2019-2022 | |
| Daiichi Sankyo INC. | $95.41 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $80.42 | 2021-2022 | |
| Aspira Women'S Health INC | $72.37 | 2022 | |
| Therapeuticsmd, INC. | $65.37 | 2019-2021 | |
| Lundbeck LLC | $50.13 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $40.49 | 2023 | |
| Pharmacosmos Therapeutics INC. | $39.72 | 2020 | |
| Myovant Sciences INC. | $34.64 | 2021-2022 | |
| Olympus America INC. | $26.54 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.28 | 2022 | |
| Csl Behring | $23.21 | 2023 | Hizentra |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $21.00 | 2020 | |
| Argenx US, INC. | $18.77 | 2023 | Vyvgart |
| Agile Therapeutics, INC. | $15.50 | 2022 | |
| Becton, Dickinson and Company | $14.91 | 2019 | |
| Minerva Surgical, INC | $14.20 | 2022 | |
| Amgen INC. | $13.05 | 2022 | |
| Allergan, INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Tatum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.